Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Psychiatry

Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia

Eser Ergün, Bilge Salanci, Aygün Ertugrul, Basaran Demir and Belkis Erbas
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 260P;
Eser Ergün
1Department of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bilge Salanci
1Department of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aygün Ertugrul
2Department of Psychiatry, Hacettepe University, School of Medicine, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Basaran Demir
2Department of Psychiatry, Hacettepe University, School of Medicine, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belkis Erbas
1Department of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1187

Objectives: In SISCOM (Subtraction Ictal SPECT Coregistred to MRI) method which has been developed for advanced evaluation of epileptic focus, interictal brain perfusion SPECT images are subtracted from ictal SPECT and the final solution is overlapped on MRI. The final image is used to optimally determine regions of altered activation during seizure. Altered rCBF in frontal cortex and basal ganglia in response to antipsychotic medication can differentiate the responders from nonresponder schizophrenic patients. Our aim was to test whether SISCOM can also be applied for the evaluation of rCBF changes due to medication in schizophrenia. Methods: 19 schizophrenic patients(9m,10f) were given clozapine treatment after one week drug free interval. Tc-99m HMPAO Brain SPECT was obtained both before(pre-SPECT) and 8 weeks after(post-SPECT) clozapine therapy. Each study was evaluated visually. Pre and post-SPECT data were subtracted from each other with SISCOM by using Analyze 6.0 workspace. SISCOM images and visual evaluation were compared with each other. Results: Final SISCOM images and visual evaluation of pre and post-SPECT studies were well concordant in 16 patients (84%) according to the basal ganglia and frontal lobe rCBF alterations. Discordance was observed in 3 patients (16%); in 1 patient alterations observed with SISCOM was confirmed as subtle changes in basal ganglia and frontal cortex on visual re-evaluation of images. In 2 patients, SISCOM did not confirm the changes observed by visual analysis. Additionally, SISCOM depicted the increased occipital rCBF better than visual evaluation in 4 patients who had visual activation during the injection of the radiopharmaceutical. Conclusions: Complementery use of SISCOM to visual evaluation in schizophrenic patients seems to be useful to assess the rCBF changes due to medication effect, provides addiditional information and makes the visual analysis easy.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia
Eser Ergün, Bilge Salanci, Aygün Ertugrul, Basaran Demir, Belkis Erbas
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 260P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia
Eser Ergün, Bilge Salanci, Aygün Ertugrul, Basaran Demir, Belkis Erbas
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 260P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Psychiatry

  • Differences in dopamine release in Tourette's syndrome and obsessive-compulsive disorder
  • Effects of trigeminal nerve stimulation on regional brain activity in depression
  • Correlation of early-phase F-18 Florbetapir (AV-45) PET images to FDG images
Show more Neurosciences: Psychiatry

Psychiatry Posters

  • Towards characterizing the regional cerebral perfusion in evaluating the severity of major depression disorder by SPECT/CT
  • A pilot PET/MR study of hippocampal, diffusivity and brain metabolism changes following electroconvulsive therapy
  • Naltrexone occupancy at kappa opioid receptors investigated in alcoholics by PET occupancy at kappa opioid receptors investigated in alcoholics by PET
Show more Psychiatry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire